Llwytho...
Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy
The correlation between tumor-infiltrating lymphocyte (TIL)-expression of programmed cell death ligand 1 (PD-L1) and clinical responsiveness to the PD-1 blocking antibody nivolumab implicates adaptive immune evasion mechanisms in cancer. We review our findings that tumor cell PD-L1 expression is ind...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oncoimmunology |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4352965/ https://ncbi.nlm.nih.gov/pubmed/25964860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954868 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|